Survey on Itch in Outpatients of a University Clinic
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Basel, Switzerland, 4031
- Department of Dermatology, University Hospital Basel
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- outpatients suffering from itch
Exclusion Criteria:
- outpatients (suffering from itch) not willing or able to participate
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
itch intensity
Time Frame: single time point assessment at baseline
|
Questions regarding itch perception (NRS 0-10; 0 = no itch, 10 = worst imaginable itch) experienced at the moment, within the last 7 days, within the last month
|
single time point assessment at baseline
|
|
itch perception
Time Frame: single time point assessment at baseline
|
Questions regarding situations in which the itch is especially bad (multiple choice options regarding day time, daily situations, season); objective assessment in which respondents are asked to select answers from the choices offered as a list
|
single time point assessment at baseline
|
|
impact of itch on quality of life
Time Frame: single time point assessment at baseline
|
Questions regarding strength of impact of itch on quality of life (NRS 0-10; 0 = no impact, 10 = extreme)
|
single time point assessment at baseline
|
|
quality of sleep
Time Frame: single time point assessment at baseline
|
Questions regarding sleep disturbance by itch (Does itch disturb the patient's sleep and/or sleep of other persons?
(yes/no))
|
single time point assessment at baseline
|
|
days missing at work
Time Frame: single time point assessment at baseline
|
Approximate number of days missing at work due to itch within last 6 months
|
single time point assessment at baseline
|
|
helpfulness of common itch therapies
Time Frame: single time point assessment at baseline
|
Questions regarding helpfulness of common itch therapies (NRS 0-10; 0 = no reduction in itch, 10 = complete reduction of itch; additionally free text options to indicate specific creams, tablets or alternative medicine) |
single time point assessment at baseline
|
|
preferred treatment options
Time Frame: single time point assessment at baseline
|
Questions regarding preferred treatment options (NRS 0- 10; 0 = unimportant, 10 = most important; including additional free text option)
|
single time point assessment at baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- UBE 15/114, sp15Mueller3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.